耗材描述

• 分子式 C₂₀H₁₉FN₈O₂
• 分子量422.42

属性

溶解性	DMSO
存贮条件	储存温度-20°C

描述

应用	Riociguat (BAY 63-2521)是可溶的鸟苷酸环化酶刺激剂。
生化机理	Riociguat (BAY 63-2521; BAY 632521) is a novel drug that is currently in clinical development by Bayer. Riociguat (BAY 63-2521; BAY 632521) is a stimulator of soluble guanylate cyclase (sGC). At the moment Phase III clinical trials investigate the use of riociguat as a new approach to treat two forms of pulmonary hypertension (PH): chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH). Riociguat constitutes the first drug of a novel class of sGC stimulators.
别名	利奥西呱;N-[4,6-二氨基-2-[1-[(2-氟苯基)甲基]-1H-吡唑并[3,4-B]吡啶-3-基]-5-嘧啶基]-N-甲基氨基甲酸甲酯;BAY 63-2521; BAY 632521;N-[4,6-Diamino-2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]-N-methylcarbamic acid methyl ester

猜你喜欢

• 

  R-Boc-4-氯苯基-beta-苯丙氨酸

• 

  C-1389Sigma羧苄青霉素

• 

  预先剪切的转印膜

• 

  Levosimendan

• 

  Torsemide

• 

  Dexpramipexole

• 

  适用于Novex®Tris-甘氨酸凝胶的预混合缓冲液和试剂

• 

  盐酸尼卡地平

• 

  Fmoc-L-2-AminoadipicAcid

• 

  Cefoperazone

感兴趣产品

• Riociguat价格
• Riociguat厂商
• Riociguat规格